LIDOCAIN 5%

LIDOCAIN 5% was reported 16 times

LIDOCAIN 5% is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 APPLICATION SITE HYPERAESTHESIA 1 0.0101
1 PSEUDOMYOPIA 1 0.0086
2 MEAN ARTERIAL PRESSURE DECREASED 1 0.0040
3 CONJUNCTIVAL DISORDER 1 0.0026
4 AMBLYOPIA 1 0.0017
5 ACCOMMODATION DISORDER 1 0.0014
6 RESUSCITATION 1 0.0006
7 BURNS SECOND DEGREE 1 0.0006
8 DRUG TOLERANCE DECREASED 1 0.0004
9 HEART VALVE INCOMPETENCE 1 0.0003
10 GUILLAIN-BARRE SYNDROME 1 0.0002
11 APPLICATION SITE SWELLING 1 0.0002
12 APPLICATION SITE PAIN 4 0.0002
13 APPLICATION SITE VESICLES 1 0.0002
14 MOTOR DYSFUNCTION 1 0.0001
15 TEMPERATURE INTOLERANCE 1 0.0001
16 FOLLICULITIS 1 0.0001
17 NO THERAPEUTIC RESPONSE 1 0.0001
18 RESPIRATORY DEPRESSION 1 0.0001
19 APPLICATION SITE ERYTHEMA 2 0.0001
20 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
21 UNRESPONSIVE TO STIMULI 1 0.0000
22 HAEMATOMA 1 0.0000
23 DRUG-INDUCED LIVER INJURY 1 0.0000
24 VISUAL ACUITY REDUCED 1 0.0000
25 BLINDNESS 1 0.0000
26 NEUROPATHY PERIPHERAL 2 0.0000
27 ANAPHYLACTIC REACTION 1 0.0000
28 EXPOSURE DURING PREGNANCY 1 0.0000
29 HEPATIC ENZYME INCREASED 1 0.0000
30 ACNE 1 0.0000
31 ADVERSE EVENT 1 0.0000
32 HYPERSENSITIVITY 2 0.0000
33 OEDEMA PERIPHERAL 1 0.0000
34 VISUAL IMPAIRMENT 1 0.0000
35 VISION BLURRED 1 0.0000
36 ACUTE KIDNEY INJURY 1 0.0000
37 TOXICITY TO VARIOUS AGENTS 1 0.0000
38 CHEST PAIN 1 0.0000
39 PRODUCT USE ISSUE 1 0.0000
40 ABDOMINAL PAIN UPPER 1 0.0000
41 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
42 INSOMNIA 1 0.0000
43 CONDITION AGGRAVATED 1 0.0000
44 PAIN 1 0.0000
45 FATIGUE 1 0.0000
46 NAUSEA 1 0.0000
47 DRUG INEFFECTIVE 1 0.0000